Home
About
Overview
Sharing Data
ORCID
Help
History (6)
Design and methods for a randomized clinical trial treating comorbid obesity and major depressive disorder.
Role of conserved tyrosine residues in NiSOD catalysis: a case of convergent evolution.
Splanchnic and cerebral vasodilatory effects of calcitonin gene-related peptide I in humans.
Treatment of children and adolescents with localized parameningeal sarcoma: experience of the Intergroup Rhabdomyosarcoma Study Group protocols IRS-II through -IV, 1978-1997.
Molecular magnetic resonance contrast agents for the detection of cancer: past and present.
See All 6 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Molecular magnetic resonance contrast agents for the detection of cancer: past and present.
Bogdanov A, Mazzanti ML. Molecular magnetic resonance contrast agents for the detection of cancer: past and present. Semin Oncol. 2011 Feb; 38(1):42-54.
View in:
PubMed
subject areas
Contrast Media
Humans
Magnetic Resonance Imaging
Molecular Imaging
Molecular Probes
Neoplasms
authors with profiles
Alexei A Bogdanov PhD